M Shrivastav1,2, A Rammohan1,2, M S Reddy1,2, M Rela1,2,3. 1. Institute of Liver Disease & Transplantation, Gleneagles Global Health City , Chennai , India. 2. Institute of Liver Disease & Transplantation, Dr.Rela Institute & Medical Centre, Bharat Institute of Higher Education & Research , Chennai , India. 3. Institute of Liver Studies, King's College Hospital , London , UK.
Abstract
INTRODUCTION: Auxiliary partial orthotopic liver transplantation (APOLT) in acute liver failure acts as a bridge to native liver regeneration with potential for immunosuppression free survival. While technical concerns limit its universal acceptance, the indications in acute liver failure also need to be examined for this procedure to ultimately succeed. CASE HISTORY: We present the case of an eight-month-old girl with cryptogenic acute liver failure who underwent APOLT. She developed postoperative liver dysfunction, most likely owing to the persistence of the diseased native liver, ultimately leading to an orthotopic retransplantation. She remains well on follow-up review. CONCLUSIONS: A tempered approach to selecting patients for APOLT (especially with regard to aetiology of acute liver failure) makes it a safe and effective alternative to orthotopic liver transplantation.
INTRODUCTION: Auxiliary partial orthotopic liver transplantation (APOLT) in acute liver failure acts as a bridge to native liver regeneration with potential for immunosuppression free survival. While technical concerns limit its universal acceptance, the indications in acute liver failure also need to be examined for this procedure to ultimately succeed. CASE HISTORY: We present the case of an eight-month-old girl with cryptogenic acute liver failure who underwent APOLT. She developed postoperative liver dysfunction, most likely owing to the persistence of the diseased native liver, ultimately leading to an orthotopic retransplantation. She remains well on follow-up review. CONCLUSIONS: A tempered approach to selecting patients for APOLT (especially with regard to aetiology of acute liver failure) makes it a safe and effective alternative to orthotopic liver transplantation.
Authors: D Azoulay; D Samuel; P Ichai; D Castaing; F Saliba; R Adam; E Savier; M Danaoui; A Smail; V Delvart; V Karam; H Bismuth Journal: Ann Surg Date: 2001-12 Impact factor: 12.969
Authors: Giacomo Germani; Eleni Theocharidou; Renè Adam; Vincent Karam; Julia Wendon; John O'Grady; Patrizia Burra; Marco Senzolo; Darius Mirza; Denis Castaing; Jurgen Klempnauer; Stephen Pollard; Andreas Paul; Jacques Belghiti; Emmanuel Tsochatzis; Andrew K Burroughs Journal: J Hepatol Date: 2012-04-18 Impact factor: 25.083
Authors: Alberto Quaglia; Bernard C Portmann; A S Knisely; Alex S Knisely; Parthi Srinivasan; Paolo Muiesan; Julia Wendon; Michael A Heneghan; John G O'Grady; Marianne Samyn; Dino Hadzic; Anil Dhawan; Giorgina Mieli-Vergani; Nigel Heaton; Mohamed Rela Journal: Liver Transpl Date: 2008-10 Impact factor: 5.799